Skip to Content

Grand Rounds

Printer Friendly Version
Date / Location Speaker Affiliation Topic
December 20, 2016
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
CANCELLED MD Anderson Cancer Center DUE TO THE HOLIDAYS
December 27, 2016
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
CANCELLED MD Anderson Cancer Center DUE TO THE HOLIDAYS
January 10, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Eduardo Bruera, MD; Lorenzo Cohen, PhD; David Hui, MD and Sriram Yennu, MD MD Anderson Cancer Center Enhancing Patient Care and Well-being through Comprehensive Innovative Research
January 17, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Division of Cancer Medicine Townhall / Q&A Meeting MD Anderson Cancer Center DoCM Townhall and Question and Answer Meeting in Lieu of Grand Rounds
January 24, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Timothy Thompson, PhD MD Anderson Cancer Center Novel Approaches to PARP Inhibitor Therapy for Prostate Cancer
January 31, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Michel Sadelain, MD, PhD Memorial Sloan-Kettering Cancer Center CAR Therapy: The CD19 Paradigm and Beyond
February 07, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Thomas J. Walsh, MD, PhD Weill Cornell Medicine of Cornell University, New York The Global Impact of Infectious Diseases Supportive Care in Patients with Cancer: Standing on the Shoulders of A Giant
February 14, 2017
AT&T Auditorium - Main Building - B2.4750
Aung Naing, MD; Timothy Yap, PhD MD Anderson Cancer Center Advances in Developmental Therapeutics Dr. Yap- PARP Inhibitors: Lessons Learnt and Unanswered Questions Dr. Naing- Update on Immunotherapy
February 21, 2017
B2.4750 AT & T Auditorium; 8:00-9:00 a.m.
Guillermo Garcia-Manero, MD MD Anderson Cancer Center Towards a Cure for Myelodysplastic Syndromes (What can MD Anderson do to help)
February 28, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Scott E. Woodman, MD, PhD MD Anderson Cancer Center Cancer Cell-Intrinsic Features of Response to Targeted and Immune Therapies in Melanoma
March 07, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Robert S. Benjamin, MD MD Anderson Cancer Center Chemotherapy for Soft-Tissue Sarcomas: Old and New Drugs
March 21, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Cliona M. Rooney, PhD Baylor College of Medicine Enhancing T-cell Immunotherapy for Cancer
March 28, 2017
B2.4750 AT&T Auditorium; 8:00-9:00 a.m.
John L. Marshall, MD Georgetown University Medical Center Finding Value in Colon Cancer
April 04, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
CANCELLED MD Anderson Cancer Center DUE TO AACR
April 11, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Jeffrey A. Engelman, MD, PhD Vice President and Global Head of Oncology, Novartis Institutes for Biomedical Research Targeted Therapies and Resistance: Where Are We Going?
April 18, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
3rd Annual T32 Symposium MD Anderson Cancer Center TBA
April 25, 2017
R11.1400 Hickey Auditorium; 8:00-9:00 a.m.
Lorraine J. Gudas, MD Weill Cornell Medical College of Cornell University Nuclear Receptor Selective Agonists for the Prevention and Treatment of Cancer and Diabetes